«Uremia

Below is an extended Uremia patents listing. Click here to return to the Uremia main in depth entry.

Patents :
US Patent No.	Title
7342083	Polyamine polymers
7368531	Human secreted proteins
7371822	Human G-protein coupled receptor variant of HM74, HGPRBMY74
7371825	Anti-MCP-1 antibodies, compositions, methods and uses
7375192	Antibodies that specifically bind to chemokine beta-4
7378423	Pyrimidine compound and medical use thereof
7378436	Compounds
7381699	Reagents and methods for smooth muscle therapies
7381747	Alpha 2 delta ligands for post-traumatic stress disorder
7381800	Antibodies to HBIMF63 polypeptide
7384558	Compositions capable of inhibiting reactive oxygen and carbonyl species
7368527	HADDE71 polypeptides
7363076	Treatment of conditions through modulation of the autonomic nervous system
7359802	Methods for remote characterization of an odor
7344860	Polynucleotide encoding a novel human P2X7 splice variant, HBMYP2X7v
7344882	Polynucleotides encoding variants of the TRP channel family member, LTRPC3
7345019	Modulation of excitable tissue function by peripherally administered erythropoietin
7345065	Methods and compositions for alleviating pain
7345148	Human G-protein coupled receptor, HGPRBMY29sv1 polypeptides
7348149	Methods of diagnosing Parkinson's disease by measuring expression level of RNA encoding human protein HLLRCR-1
7354925	Alpha aryl or heteroaryl methyl beta piperidino propanamide compounds as ORL1-receptor antagonists
7354941	Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of PDE4 isozymes
7355001	Organic anion transport protein TCH229
7358074	Human phosphatase RET31, and variants thereof
7385012	Polyamine polymers
7385036	Human tango 509 polypeptides
7411051	Antibodies to HDPPA04 polypeptide
7414071	Methods of treatment with selective EP4 receptor agonists
7417048	Aryl-substituted derivatives of cycloalkyl and branched chain alkyl carboxylic acids useful as antinociceptive drugs for peripheral targets
7417121	Human G-protein coupled receptor, HGPRBMY39
7419981	Synergistic combinations of an alpha-2-delta ligand and a cGMP phosphodieterse 5 inhibitor
7422847	Human E3.alpha. ubiquitin ligase family
7423017	Method for treating cartilage disorders
7423054	Therapeutic pyrazolo[3,4-b]pyridines and indazoles
7427471	Modified "S" antibodies
7429394	Ion binding compositions
7411001	Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
7410954	Adenovirus serotype 30 (Ad30)
7410941	Methods for treatment of neurodegenerative conditions by peripherally administered erythropoietin
7388023	Amino acids with affinity for the .alpha.2.delta.-protein
7390637	Keratinocyte derived interferon
7390659	Methods for inducing differentiation of embryonic stem cells and uses thereof
7393872	Sodium channel blocker compositions and the use thereof
7393921	Prostate-specific polypeptide pamp and encoding nucleic acid molecules
7396858	Biguanide derivative and therapeutic agent for diabetes containing the same
7396946	Compound for treatment of external secretion disorders
7399740	Poly-Glu,Tyr for neuroprotective therapy
7402564	Synthetic peptide amides
7407936	Use of copolymer 1 and related peptides and polypeptides and T cells treated herewith for neuroprotective glaucoma therapy
7429560	Ketoamide inhibitors in chronic nerve disease

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.